Precisely designed products paired with highly customizable services.
Founded in 2012 by Mayo scientists pioneering virus and gene therapies for oncology, we designed our products and services on firsthand research expertise.
We know what it takes to make breakthroughs in vector-driven, immune-oncology therapeutics because we’re doing it every day. We’ve advanced novel oncolytic viruses, innovated in vivo vector targeting strategies, and built precision-editing platforms.
We provide the specialized tools that viral, gene, and cell therapy researchers need, including research-grade cells, vectors, assays, and contract research.
We take a hands-on approach to help customers identify the best products and services for their specific research, relying on our scientific expertise to design custom solutions when needed.
Validated particle targeting reagents and oncology tumor models with as much characterization data as you need.
When catalog products don’t fit your requirements or you need an experienced scientific team to carry out your studies.
Cell lines built and characterized to your exact research requirements.
Custom lentiviral and AAV vectors cloned, packaged, and characterized.
Purpose-built assays to thoroughly characterize your vectors, cells, and therapies.
Contract research for virus and vector-based therapies.
Products that discovery-stage researchers need to push experimental therapies closer to the clinic. Backed by scientists who’ve been there.
